Abbott ID NOW COVID-19 test gets FDA nod to detect coronavirus in 5 mins

Abbott ID NOW COVID-19 test : Medical device company Abbott has been granted Emergency Use Authorization (EUA) for its five-minute novel coronavirus diagnostic test from the US Food and Drug Administration (FDA). The company has launched the coronavirus detection test following the FDA approval. According to Abbott, the ID NOW platform is the fastest More...

by pharmanewsdaily | Published 2 days ago
By Soujanya Ravi On Saturday, March 28th, 2020
0 Comments

behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal

behold.ai claimed that its artificial intelligence-based red dot algorithm has been shown to have quickly identified chest X-rays from COVID-19 patients as ‘abnormal’. The UK-based healthtech company expects More...

By pharmanewsdaily On Friday, March 27th, 2020
0 Comments

BioDuro launches AI-driven COVID-19 nanobody therapeutic program

BioDuro said that it has launched a COVID-19 nanobody therapeutic program by leveraging its biologics discovery platform, which makes use of artificial intelligence computing and high-speed DNA mutagenesis technology. The More...

By Soujanya Ravi On Thursday, March 26th, 2020
0 Comments

RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford

RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called the Randomised Evaluation of COVid-19 thERapY (RECOVERY) trial. The RECOVERY clinical trial, More...

By pharmanewsdaily On Wednesday, March 25th, 2020
0 Comments

BreathTest-1000 coronavirus screening instrument developed by Astrotech

BreathTest-1000 coronavirus screening instrument : Astrotech said that it is developing the BreathTest-1000 screening instrument for coronavirus (COVID-19) and the associated pneumonia, and also other lung diseases. The More...

By pharmanewsdaily On Tuesday, March 24th, 2020
0 Comments

Actemra coronavirus clinical trial : Genentech gets FDA nod for COVID-19 trial

Actemra coronavirus clinical trial : Genentech has been given approval by the US Food & Drug Administration (FDA) to undertake the phase 3 COVACTA trial to assess the safety and efficacy of intravenous Actemra More...

By pharmanewsdaily On Sunday, March 22nd, 2020
0 Comments

Coronavirus home testing kit launched by US health tech company Nurx

US health tech company Nurx has unveiled a coronavirus home testing kit apart from launching an online coronavirus consultation service to address the COVID-19 pandemic, which has already infected more than 25,000 More...

By pharmanewsdaily On Sunday, March 22nd, 2020
0 Comments

Health Recovery Solutions launches telehealth COVID-Kit across US

Health Recovery Solutions (HRS), a US-based provider of telehealth and remote patient monitoring solutions, said that its telehealth COVID-Kit is available to all providers. The company said that its COVID-Kit is More...

By pharmanewsdaily On Friday, March 20th, 2020
0 Comments

Gilead Sciences bags Epclusa FDA approval for hepatitis C in pediatric patients

Epclusa FDA approval : Gilead Sciences has secured an expanded approval for Epclusa (sofosbuvir 400mg/velpatasvir 100mg; sofosbuvir 200mg/velpatasvir 50 mg) from the US Food and Drug Administration (FDA), which More...

By pharmanewsdaily On Friday, March 20th, 2020
0 Comments

Polarisqb, Fujitsu join forces to create dengue drug discovery platform

Polarisqb has joined forces with Fujitsu to create a Dengue drug discovery platform that brings together quantum-inspired technology, hybrid quantum mechanics, machine learning, and molecular mechanics simulations More...